Cargando…

Pediatric non-clinical drug testing : principles, requirements, and practice /

"This book explains the importance and practice of pediatric drug testing for pharmaceutical and toxicology professionals. It describes the practical and ethical issues regarding non-clinical testing to meet US FDA Guidelines, differences resulting from the new European EMEA legislation, and ho...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Hoberman, Alan M., Lewis, Elise M.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken, N.J. : John Wiley & Sons, 2012.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 EBOOKCENTRAL_ocn823731502
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 111018s2012 njua ob 000 0 eng d
010 |z  2011043323 
040 |a E7B  |b eng  |e pn  |c E7B  |d OCLCQ  |d OCLCO  |d N$T  |d YDXCP  |d CDX  |d RECBK  |d EBLCP  |d CN3GA  |d OCLCQ  |d COO  |d OCLCQ  |d OCLCF  |d AZK  |d COCUF  |d MOR  |d PIFAG  |d MERUC  |d OCLCQ  |d OCLCO  |d ZCU  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d STF  |d WRM  |d ICG  |d NRAMU  |d VT2  |d AU@  |d OCLCO  |d WYU  |d OCLCO  |d OCLCA  |d DKC  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d UKCRE  |d UKAHL  |d VHC  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
019 |a 775301847  |a 794619902  |a 898985096  |a 961515278  |a 962633257  |a 988497207  |a 991962611  |a 1037722738  |a 1038610825  |a 1045522484  |a 1058929611  |a 1066048349  |a 1081263010  |a 1153549620  |a 1162012742  |a 1228581769  |a 1290043067  |a 1303520490 
020 |a 9781118168264  |q (electronic bk.) 
020 |a 1118168267  |q (electronic bk.) 
020 |a 047044861X 
020 |a 9780470448618 
020 |a 9781118168257  |q (electronic bk.) 
020 |a 1118168259  |q (electronic bk.) 
020 |a 9781118168226  |q (electronic bk.) 
020 |a 1118168224  |q (electronic bk.) 
020 |z 9780470448618  |q (cloth) 
020 |z 9781280590429  |q (MyiLibrary) 
020 |z 1280590424  |q (MyiLibrary) 
020 |a 9786613620255 
020 |a 6613620254 
024 8 |a 9786613620255 
028 0 1 |a EB00062870  |b Recorded Books 
029 1 |a DEBBG  |b BV040885364 
029 1 |a DEBBG  |b BV041049591 
029 1 |a DEBBG  |b BV044159819 
029 1 |a NZ1  |b 14976854 
035 |a (OCoLC)823731502  |z (OCoLC)775301847  |z (OCoLC)794619902  |z (OCoLC)898985096  |z (OCoLC)961515278  |z (OCoLC)962633257  |z (OCoLC)988497207  |z (OCoLC)991962611  |z (OCoLC)1037722738  |z (OCoLC)1038610825  |z (OCoLC)1045522484  |z (OCoLC)1058929611  |z (OCoLC)1066048349  |z (OCoLC)1081263010  |z (OCoLC)1153549620  |z (OCoLC)1162012742  |z (OCoLC)1228581769  |z (OCoLC)1290043067  |z (OCoLC)1303520490 
037 |a 362025  |b MIL 
043 |a n-us--- 
050 4 |a RM301.25  |b .P43 2012eb 
060 4 |a QV 771 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615.7/040287  |2 23 
049 |a UAMI 
245 0 0 |a Pediatric non-clinical drug testing :  |b principles, requirements, and practice /  |c edited by Alan M. Hoberman, Elise M. Lewis. 
260 |a Hoboken, N.J. :  |b John Wiley & Sons,  |c 2012. 
300 |a 1 online resource (xv, 339 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
504 |a Includes bibliographical references. 
520 |a "This book explains the importance and practice of pediatric drug testing for pharmaceutical and toxicology professionals. It describes the practical and ethical issues regarding non-clinical testing to meet US FDA Guidelines, differences resulting from the new European EMEA legislation, and how to develop appropriate information for submission to both agencies. It also provides practical study designs and approaches that can be used to meet international requirements. Covering the full scope of non-clinical testing, regulations, models, practice, and relation to clinical trials, this text offers a comprehensive and up-to-date resource"--Provided by publisher. 
505 0 |a Pediatric Nonclinical Drug Testing; Contents; Preface; Acknowledgments; Contributors; 1. Introduction; 2. Overview of Pediatric Diseases and Clinical Considerations on Developing Medicines for Children; 3. Nonclinical Safety Assessment for Biopharmaceuticals: Challenges and Strategies for Juvenile Animal Testing; 4. FDA Approach to Pediatric Testing; 5. Pediatric Drug Development Plans; 6. Application of Principles of Nonclinical Pediatric Drug Testing to the Hazard Evaluation of Environmental Contaminants; 7. Nonclinical Testing Procedures--Pharmacokinetics. 
505 8 |a 8. Preclinical Development of a Pharmaceutical Product for Children9. Juvenile Toxicity Study Design for the Rodent and Rabbit; 10. Dog Juvenile Toxicity; 11. Use of the Swine Pediatric Model; 12. Juvenile Immunodevelopment in Minipigs; 13. Use of Primate Pediatric Model; 14. Approaches to Rat Juvenile Toxicity Studies and Case Studies: a Pharmaceutical Perspective; Appendix 1 Maturation of Organ Systems in Various Species; Appendix 2 Sample Juvenile Toxicity Testing Protocol; Index. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Drug development  |z United States. 
650 0 |a Pediatric pharmacology  |z United States. 
650 0 |a Pediatrics  |z United States  |v Formulae, receipts, prescriptions  |x Safety measures. 
650 0 |a Age factors in disease. 
650 0 |a Children. 
650 0 |a Infants. 
650 1 2 |a Drug Evaluation, Preclinical 
650 2 2 |a Drug-Related Side Effects and Adverse Reactions  |x prevention & control 
650 2 2 |a Age Factors 
650 2 2 |a Child 
650 2 2 |a Drug Approval 
650 2 2 |a Infant 
650 2 2 |a Models, Animal 
651 2 |a United States 
650 6 |a Médicaments  |x Développement  |z États-Unis. 
650 6 |a Pharmacologie pédiatrique  |z États-Unis. 
650 6 |a Pédiatrie  |z États-Unis  |v Formules et recettes  |x Sécurité  |x Mesures. 
650 6 |a Maladies  |x Facteurs liés à l'âge. 
650 6 |a Enfants. 
650 6 |a Nourrissons. 
650 7 |a children (people by age group)  |2 aat 
650 7 |a infants.  |2 aat 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Infants  |2 fast 
650 7 |a Children  |2 fast 
650 7 |a Age factors in disease  |2 fast 
650 7 |a Drug development  |2 fast 
650 7 |a Pediatric pharmacology  |2 fast 
650 7 |a Pediatrics  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
700 1 |a Hoberman, Alan M. 
700 1 |a Lewis, Elise M. 
758 |i has work:  |a Pediatric nonclinical drug testing (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGdBRCWgPQYMDgbBWrmgTd  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Pediatric non-clinical drug testing.  |d Hoboken, N.J. : John Wiley & Sons, 2012  |w (DLC) 2011043323 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=818510  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH21626355 
938 |a Coutts Information Services  |b COUT  |n 22302941 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL818510 
938 |a ebrary  |b EBRY  |n ebr10630570 
938 |a EBSCOhost  |b EBSC  |n 535831 
938 |a Recorded Books, LLC  |b RECE  |n rbeEB00062870 
938 |a YBP Library Services  |b YANK  |n 9339837 
938 |a YBP Library Services  |b YANK  |n 7119902 
994 |a 92  |b IZTAP